Publication

Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Chester J. Joyner, Emory UniversityCristiana F. A. Brito, Emory UniversityCelia L. Saney, Emory UniversityRegina Joice Cordy, Emory UniversityMaren L. Smith, Emory UniversityStacey A. Lapp, Emory UniversityMonica Cabrera-Mora, Emory UniversityShuya Kyu, Emory UniversityNicolas Lackman, Emory UniversityMustafa V. Nural, Emory UniversityJeremy D. DeBarry, Emory UniversityJessica C. Kissinger, Emory UniversityF. Eun-Hyung Lee, Emory UniversityMark P. Styczynski, Emory UniversityTracey J. Lamb, Emory UniversityMary Galinski, Emory University
Language
  • English
Date
  • 2019-09-01
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • Copyright © 2019 Joyner et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1553-7366
Volume
  • 15
Issue
  • 9
Start Page
  • e1007974
End Page
  • e1007974
Grant/Funding Information
  • This project was funded in part by Federal funds from the US National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov), National Institutes of Health, Department of Health and Human Services under contract # HHSN272201200031C (PI: Mary R. Galinski), which established the Malaria Host-Pathogen Interaction Center (MaHPIC), as well as the Office of Research Infrastructure Programs/OD P51OD011132. The Yerkes NHP Genomics Core is supported in part by ORIP/OD P51OD011132.
  • Additional support was provided by 1R01AI121252, 1P01AI125180, P01A1078907, U19AI109962, and 1R01AI123425.
Supplemental Material (URL)
Abstract
  • Plasmodium relapses are attributed to the activation of dormant liver-stage parasites and are responsible for a significant number of recurring malaria blood-stage infections. While characteristic of human infections caused by P. vivax and P. ovale, their relative contribution to malaria disease burden and transmission remains poorly understood. This is largely because it is difficult to identify 'bona fide' relapse infections due to ongoing transmission in most endemic areas. Here, we use the P. cynomolgi-rhesus macaque model of relapsing malaria to demonstrate that clinical immunity can form after a single sporozoite-initiated blood-stage infection and prevent illness during relapses and homologous reinfections. By integrating data from whole blood RNA-sequencing, flow cytometry, P. cynomolgi-specific ELISAs, and opsonic phagocytosis assays, we demonstrate that this immunity is associated with a rapid recall response by memory B cells that expand and produce anti-parasite IgG1 that can mediate parasite clearance of relapsing parasites. The reduction in parasitemia during relapses was mirrored by a reduction in the total number of circulating gametocytes, but importantly, the cumulative proportion of gametocytes increased during relapses. Overall, this study reveals that P. cynomolgi relapse infections can be clinically silent in macaques due to rapid memory B cell responses that help to clear asexual-stage parasites but still carry gametocytes.
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Parasitology
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items